Authors
Latest:
Augmented Intelligence Can Help Reduce Unplanned Hospital Admissions, Supporting the Enhancing Oncology ModelEven with technological advancements, provider involvement and oversight remain essential.
Latest:
Risks and Impacts of Cannabis Use During Pregnancy: A Growing Concern for Neonatal HealthCannabis use during pregnancy may harm fetal development and long-term health.
Latest:
Ensuring Innovation Act Changes Eligibility for New Chemical ExclusivityLaw aims to encourage competition in the pharmaceutical industry, making it easier for generics to enter market.
Latest:
From Trial to Practice in the Evolving Landscape of Hematologic MalignanciesTim Mok, PharmD, BCOP, BCPS, discusses emerging advancements in treatment of leukemia and lymphoma.
Latest:
Leveraging Technology to Enhance Women’s Health and Access to CarePanelists discuss how digital health technologies revolutionize women’s health care through telehealth, mobile apps, and remote monitoring, expanding access, personalization, and proactive medical support.
Latest:
MHPAEA Has Positive Effect on Psychiatric CareMental Health Parity and Addiction Equity Act disallows insurers offering lower-quality benefits for behavioral health treatments.
Latest:
Improving Seniors’ Timely Access to Care Act Aims to Improve Prior Authorization ProcessLegislation would place emphasis back on patient health rather than on cumbersome, time-consuming paperwork.
Latest:
FDA, USP Advance Standardization, Regulation of Cannabis NationallyQuality standards and national regulation help to establish its role as medicine.
Latest:
Nuclear Isotopes Could Help Address Challenges in Oncology Clinical TrialsThe radiation emerging from these isotopes can be used in 2 different ways in cancer trials: imaging (detection of tumors) and therapy (destruction of tumors).
Latest:
AI Tools Can Help Pharmacies Advance Value-Based Care PracticesFor pharmacies, AI and other technologies are key to thriving in the era of value-based care.
Latest:
The Blood Detective: Tackling Medication-Induced Hematological DisordersThese disorders can be fatal, making pharmacists’ role in detection crucial.
Latest:
Clinical Overview: Baricitinib (Olumiant) for Rheumatoid Arthritis, COVID-19Baricitinib (Olumiant) is indicated for the treatment of rheumatoid arthritis and COVID-19 in hospitalized adults.
Latest:
The Value of a Hub in a Limited Distribution Specialty Pharmacy NetworkAlthough specialty pharmacies may be able to offer some of the services that a hub provider does, a hub can standardize patient and provider support across the network.
Latest:
SGLT-2 Inhibitors Associated with Reduced Hyperkalemia in Patients With Heart FailureSGLT-2 inhibitors reduce cardiovascular deaths, heart failure hospitalizations, hyperkalemia, and decline of renal function in patients with HFrEF.
Latest:
Advice for Physicians to Manage C. Difficile Infection (CDI)Experts share advice for physicians taking care of patients with C. difficile infection (CDI).
Latest:
Clinical Overview: 2023-2024 COVID-19 VaccinesAn overview of updated CDC ACIP recommendations for COVID-19 vaccines available through commercial channels for the 2023-2024 season.
Latest:
Expert: Leveraging AI to Improve Biosimilar Adoption and Cost SavingsAI can streamline biosimilar adoption by simplifying prescribing decisions and reducing costs.
Latest:
Patient Case Study: A Rare Neurological Disease Diagnostic JourneyNeuromyelitis optica spectrum disorder is an autoimmune disease characterized by severe attacks of optic neuritis and/or myelitis, leading to possible visual loss, paralysis, cognitive impairment, sensory deficits, bladder dysfunction, and even mortality.
Latest:
Five Domains, One Outcome: How Social Factors Shape Cancer SurvivalIman Ahmed, PharmD, BCOP, shared key insights about how social determinants of health impact treatment access and outcomes for patients with leukemia.
Latest:
In a Nod to Precision Oncology, the FDA Approves RevumenibThe approval marks a significant milestone in the treatment of a rare and aggressive subtype of acute leukemia.
Latest:
How AI Is Helping Researchers Fight Superbugs Faster Than Ever BeforeAI may help to significantly speed up drug discovery and development, and help researchers end the treatment-resistant infection crisis before it’s too late.
Latest:
Evaluation of a Pharmacy-Delivered Oncofertility InterventionThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
Ryan’s Law Is a Monumental Opportunity for PharmacistsPharmacists can help to usher in a new era of patient-centered end-of-life care.
Latest:
Personalized Oncology Can Profoundly Impact Patients Without Negatively Impacting PayersThe drive for personalized approaches to cancer have helped to create treatments for patients with rare cancers who have few, if any, options.
Latest:
The Impact of Pharmacist-Managed Insulin Therapy in the Intensive Care UnitCritically ill patients treated with a pharmacist-managed insulin protocol achieved higher rates of glucose control than those treated with conventional methods.
Latest:
Pharmacists Reimagine Myeloma Care With Insights from ASCOGabe Hinojosa, PharmD, BCOP, shares key data for pharmacists from the 2025 American Society of Clinical Oncology Annual Meeting.
Latest:
Examining the True Cost of Carve-out Savings: Quality Clinical CareAs the price tags for therapies coming to market have soared into the hundreds of thousands and even millions on occasion, paying for them has become an ever-greater cause of concern and focus area.
Latest:
AAN 2025: Patient Voices Key to Understanding Broader Benefits of Xywav in Sleep DisordersLogan Schneider, MD, highlights the importance of integrating patient-reported outcomes into clinical trials to better capture the full therapeutic impact of low-sodium oxybate (Xywav) beyond traditional sleep metrics.
